Not applicableLooking for participantsNCT07068126What this trial is testingManagement of Children With Persistent ITP, A Novel ApproachWho this might be right forPersistent Immune Thrombocytopenia Assiut University 20
Testing effectiveness (Phase 2)Study completedNCT06287567What this trial is testingLusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)Who this might be right forIdiopathic Thrombocytopenic PurpuraImmune Thrombocytopenia Institute of Hematology & Blood Diseases Hospital, China 17
Large-scale testing (Phase 3)Active Not RecruitingNCT04562766What this trial is testingStudy to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Principia Biopharma, a Sanofi Company 232
Testing effectiveness (Phase 2)Ended earlyNCT02401061What this trial is testingPRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITPWho this might be right forImmune Thrombocytopenia Protalex, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT01129024What this trial is testingAn Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Shionogi 19
Large-scale testing (Phase 3)Study completedNCT02076399What this trial is testingA Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals 76
Not applicableNo Longer AvailableNCT03363334What this trial is testingExpanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITPWho this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083739What this trial is testingA Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in AdultsWho this might be right forPrimary Immune Thrombocytopenia Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 320
Large-scale testing (Phase 3)UnknownNCT03177629What this trial is testingH. Pylori Eradication for Moderate ITPWho this might be right forImmune Thrombocytopenic PurpuraHelicobacter PyloriImmune Thrombocytopenia Seoul National University Hospital 54
Testing effectiveness (Phase 2)Ended earlyNCT01054443What this trial is testingInvestigate the Efficacy and Safety of Lusutrombopag (S-888711) Tablets Administered to Adults With Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia (ITP) Shionogi 20
Large-scale testing (Phase 3)Looking for participantsNCT05338190What this trial is testingEfficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia (ITP) Assistance Publique - Hôpitaux de Paris 132
Not applicableStudy completedNCT03154385What this trial is testingEfficacy and Safety Assessment of a Treatment Combining Rituximab and Belimumab in Adults With Persistent Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Assistance Publique - Hôpitaux de Paris 15
Large-scale testing (Phase 3)Study completedNCT02077192What this trial is testingOpen Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)Who this might be right forImmune Thrombocytopenic Purpura Rigel Pharmaceuticals 123
Large-scale testing (Phase 3)Study completedNCT02868099What this trial is testingEfficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Not applicableEnded earlyNCT01386723What this trial is testingEnd of EXTEND: Discontinuation of Medication for Patients With Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Weill Medical College of Cornell University 35
Post-approval studies (Phase 4)Study completedNCT03119974What this trial is testingRate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITPWho this might be right forPersistent or Chronic ITP Assistance Publique - Hôpitaux de Paris 48
Testing effectiveness (Phase 2)Study completedNCT04278924What this trial is testingTAK-079 in Adults With Persistent/Chronic Primary Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia Takeda 41
Testing effectiveness (Phase 2)Ended earlyNCT02566603What this trial is testingPRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITPWho this might be right forImmune Thrombocytopenia Protalex, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT04669600What this trial is testingA Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia (ITP) Bioverativ, a Sanofi company 12
Testing effectiveness (Phase 2)Study completedNCT04056195What this trial is testingStudy of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia Oscotec Inc. 61